Giovanni Camussi

This inventor holds 19 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 19 EPO patents. Top assignees: Fresenius Medical Care Deutschland Gmbh, Unicyte Ev Ag, Presenius Medical Care Deutschland Gmbh. Active years: 2013-2025.

USPTO Granted Patents = 19 (Patent Applications = 11)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 19 (Patent Applications = 28)

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 44(Granted Patents)

Location History:

Torino, IT (2015)
Turin, IT (2013 - 2022)

Company Filing History:

11 out of 883

Fresenius Medical Care Deutschland Gmbh

Presenius Medical Care Deutschland Gmbh

Years Active: 2013-2025

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12239671 - Extracellular vesicles derived from human liver stem cells (HLSCs) (2025-03-04),

2. 12208120 - Composition of extracellular vesicles (EVS) and medical uses thereof (2025-01-28),

3. 11484816 - Isolation of extracellular vesicles (EVs) from biological fluid samples (2022-11-01),

4. 11464799 - Composition of extracellular vesicles (EVS) and medical uses thereof (2022-10-11),

5. 11453863 - Pancreatic islet-like cell structures and a method of preparing thereof (2022-09-27),

6. 11395832 - Pharmaceutical carriers containing miRNAs for use in the treatment of renal cancer (2022-07-26),

7. 11110130 - Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia (2021-09-07),

8. 10716813 - Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia (2020-07-21),

9. 10456425 - Conditioned medium of liver progenitor cells (2019-10-29),

10. 10357519 - Conditioned medium of liver progenitor cells (2019-07-23),

11. 10174286 - Pancreatic islet-like cell structures and a method of preparing thereof (2019-01-08),

12. 10105395 - Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease (2018-10-23),

13. 9717760 - Microvesicles (MVS) derived from adult stem cells for use in the therapeutic treatment of a tumor disease (2017-08-01),

14. 9499796 - Isolated multipotent mesenchymal stem cell from human adult glomeruli (HGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney (2016-11-22),

15. 9334479 - Liver progenitor cells (2016-05-10),

Title: Giovanni Camussi - Innovator in Extracellular Vesicle Research

Introduction

Giovanni Camussi is a prominent inventor located in Turin, Italy, recognized for his significant contributions to the field of biomedical research, particularly in the development and therapeutic applications of extracellular vesicles. With a remarkable portfolio of 19 patents, he has established himself as a leading figure in innovation related to cellular therapies and regenerative medicine.

Latest Patents

Camussi's latest patents feature groundbreaking work involving extracellular vesicles derived from human liver stem cells (HLSCs). His first notable patent discloses a preparation of these extracellular vesicles, which are capable of reducing the senescence of a population of senescent cells, as evaluated by a SA-β-galactosidase-based cellular senescence assay. The therapeutic applications include methods for mitigating the effects of aging and related diseases such as atherosclerosis and type 2 diabetes.

Another significant patent focuses on the compositions of extracellular vesicles (EVs) characterized by strong proangiogenic activity. These compositions are intended for therapeutic treatments of ischemic diseases and injuries, and include methods for manufacturing pharmaceutical preparations of EVs optimized for healing and tissue regeneration.

Career Highlights

Throughout his career, Giovanni Camussi has worked with notable organizations, including Fresenius Medical Care Deutschland GmbH and Unicyte Ev AG. His work in these companies has emphasized the development of innovative medical technologies and improved therapies for patients suffering from chronic diseases.

Collaborations

Camussi has collaborated with esteemed colleagues in the field, including Ciro Tetta and Maria Beatriz Herrera Sanchez. These partnerships have contributed to advancing research and expanding the horizons of technology in cellular treatment.

Conclusion

Giovanni Camussi's innovative spirit and commitment to research have established him as a leading inventor in the field of extracellular vesicles. His patents not only reflect his expertise but also offer promising therapeutic solutions to longstanding health challenges. His work continues to inspire advancements in regenerative medicine and therapeutic applications, proving invaluable to both the scientific community and patients alike.